Seres Therapeutics Inc (MCRB)
10.08
+1.00
(+11.01%)
USD |
NASDAQ |
Apr 25, 16:00
10.24
+0.16
(+1.59%)
After-Hours: 20:00
Seres Therapeutics Max Drawdown (5Y): 98.54% for March 31, 2025
View 4,000+ Financial Data Types:
Add
Browse
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Cellectar Biosciences Inc | 99.71% |
| Akebia Therapeutics Inc | 98.61% |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 98.13% |
| Theriva Biologics Inc | 99.80% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -71.04 |
| Beta (5Y) | 2.541 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 240.2% |
| Historical Sharpe Ratio (5Y) | -0.1266 |
| Historical Sortino (5Y) | -0.5959 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 38.74% |